Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PIK3CA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LAMTOR3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GTSE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPSECS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FRYL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCDC59 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C8orf44-SGK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TPR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR146A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
BRCC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMU1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITPKB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITGB1BP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COX7C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED28 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYP2U1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HELQ - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR37 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF157 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on